Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Drugs Made In America Acquisition (DMAA) Interest & Investment Income (2025)

Drugs Made In America Acquisition filings provide 1 years of Interest & Investment Income readings, the most recent being $2.3 million for Q4 2025.

  • Quarterly Interest & Investment Income changed N/A to $2.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.8 million through Dec 2025, changed N/A year-over-year, with the annual reading at $8.8 million for FY2025, N/A changed from the prior year.
  • Interest & Investment Income hit $2.3 million in Q4 2025 for Drugs Made In America Acquisition, down from $2.4 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $2.4 million in Q3 2025 and bottomed at $1.6 million in Q1 2025.